secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adicet Bio, Inc. (ACET)
CIK:        0001720580
Form:       8-K
Filed at:   2025-12-29T23:59:59+00:00
Accession:  0001193125-25-332343
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adicet Bio announces 1-for-16 reverse stock split effective Dec 30, 2025; reduces shares from ~153.3M to ~9.6M
--------------------------------------------------------------------------------

- Board approved 1-for-16 reverse split within previously authorized 1:5 to 1:30 range; effective 12:01 a.m. ET Dec 30, 2025.
- Outstanding shares drop from ~153.3 million to ~9.6 million; authorized shares unchanged at 300 million.
- Purpose: regain compliance with Nasdaq minimum bid price requirement for continued listing.
- No fractional shares issued; holders receive cash in lieu; proportional adjustments to equity plans and warrants.
- CUSIP number changes to 007002207; trading symbol remains ACET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720580/000119312525332343/0001193125-25-332343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720580/000119312525332343/acet-20251226.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-332343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer